![](/img/cover-not-exists.png)
PCN116 BUDGET-IMPACT ANALYSIS OF THE INTRODUCTION OF REGORAFENIB IN BRAZILIAN SUPPLEMENTARY HEALTHCARE SYSTEM AS A SECOND-LINE TREATMENT FOR PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA PREVIOUSLY TREATED WITH SORAFENIB
Bergamelli Ramos, N., Palhares, R., Yamamoto, L., Paladini, L., Pegoretti Rosa, B., Nardi, E.P., Saad, R.Volume:
22
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.04.240
Date:
May, 2019
File:
PDF, 382 KB
english, 2019